I spoke yesterday with NIQ CEO Jim Peck after his consumer intelligence firm had debuted on the New York Stock Exchange.

CEOs of Nestle and Reckitt are shedding brands to boost growth after predecessors' soured bets, facing challenges ...

Waystar has agreed to acquire Iodine Software, is an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and ...

After Advent's Felix Pharma buyout, another deal is brewing in the vet medicine segment. Multiples and other investors of ...

Shares in the FTSE 100 firm, which also owns Dettol cleaner and Nurofen painkillers, soared 10%, or 502p, to 5542p - a ...

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

The consumer goods giant said it had a "strong first half performance" after implementing a "significant simplification drive" last year - and said there was "much work to do" ...

Reckitt announced that it would focus on these 'Powerbrands' and sell off home care brands it no longer considers ‘core’.

Reckitt Benckiser has upgraded forecasts for its annual sales growth as the drive to simplify the health, hygiene and ...

Revenue rose 2.9% on an organic basis in the first half of the year, in line with analyst estimates. Nestle shares fell 5% in ...

Extends Waystar's AI leadership into clinical intelligence software, unlocking greater value for clients and shareholders Highly recurring subscription-based business ...